| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.3M | +35.1% |
| SG&A Expense | $23.6M | +15.9% |
| Operating Income | -$64.0M | -27.3% |
| Pre-tax Income | -$62.8M | -25.5% |
| Income Tax | $240K | -86.6% |
| Net Income | -$63.0M | -21.6% |
| EPS (Basic) | -$2.52 | -1.2% |
| EPS (Diluted) | -$2.52 | -1.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -5.1% |
| Current Assets | $108.0M | -34.2% |
| Total Assets | $123.4M | -33.1% |
| Current Liabilities | $22.4M | +9.3% |
| Total Liabilities | $41.6M | -2.8% |
| Stockholders' Equity | $81.8M | -42.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.9M | -31.9% |
| Capital Expenditures | $463K | -37.9% |
| Investing Cash Flow | $55.1M | +154.6% |
| Financing Cash Flow | -$213K | -100.1% |
| Free Cash Flow | -$57.4M | -30.7% |